Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine for Smoking Cessation in Depression-Prone Smokers
NCT00018174Phase 3Completed
- Sponsor
- United States Department of Veterans Affairs
- Start
- Feb 1998
- Primary completion
- Jan 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in nicotine dependence comparing Fluoxetine with Placebo (2 arms). Primary endpoint: Abstinence from smoking at 6 months. Started Feb 1998; status: completed.
02
Drugs
fluoxetine
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT00018174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00018174.